Jeremy M Levin insider trades: Ovid Therapeutics (OVID) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeremy reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | OVID | ↑ Buy | 18,248 | $2.76 | $50K | Direct | Mar 20, 2024 (2d) |
| Aug 28, 2020 | OVID | ↑ Buy | 8,488 | $5.84 | $50K | Direct | Sep 1, 2020 (4d) |
| Oct 8, 2019 | OVID | ↑ Buy | 60,000 | $2.50 | $150K | Direct | Oct 10, 2019 (2d) |
| Feb 22, 2019 | OVID | ↑ Buy | 75,000 | $2.00 | $150K | Direct | Feb 26, 2019 (4d) |
| Aug 25, 2017 | OVID | ↑ Buy | 15,334 | $7.15 | $110K | Direct | Aug 28, 2017 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OVID insiders
Open-market trades in the last 12 months
About Jeremy M Levin's insider trades
Jeremy M Levin is an insider at Ovid Therapeutics (OVID). Since Aug 25, 2017, Jeremy has reported 5 open-market purchases worth $510K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (11 filings), option exercises (5 filings), shares withheld for taxes (5 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OVID insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.